Skip to main content
. Author manuscript; available in PMC: 2018 Feb 15.
Published in final edited form as: Int J Cancer. 2016 Nov 14;140(4):764–776. doi: 10.1002/ijc.30494

Table 2.

Distribution of participant characteristics across WCRF/AICR score categories

Nurses’ Health Study; 1990

Characteristic 0 to ≤2 (least adherent) (n1=211) >2 to ≤3 (n1=2,007) >3 to ≤4 (n1=4,619) >4 to ≤5 (n1=3,992) >5 to 6 (most adherent) (n1=513)
Plasma biomarkers [geometric mean ± CV]2
 C-reactive protein (mg/L) 3.3 ± 1.0 2.2 ± 1.3 1.6 ± 1.4 1.2 ± 1.4 1.1 ± 1.3
 Interleukin-6 (pg/mL) 2.0 ± 1.2 1.5 ± 1.0 1.3 ± 1.0 1.1 ± 1.1 1.1 ± 1.0
 Tumor necrosis factor alpha receptor 2 (ng/ml) 2.7 ± 0.6 2.7 ± 0.6 2.5 ± 0.6 2.5 ± 0.6 2.5 ± 0.6
 Adiponectin (μg/mL) 10.0 ± 0.8 9.0 ± 0.8 10.0 ± 0.8 11.0 ± 0.8 12.2 ± 0.8
 C-peptide (ng/mL) 3.0 ± 1.0 2.7 ± 0.9 2.2 ± 0.9 1.8 ± 0.9 1.8 ± 0.8
 TG/HDL ratio 3.0 ± 1.1 2.5 ± 1.1 2.2 ± 1.0 1.8 ± 0.9 1.6 ± 1.0
 Estrone (pg/mL)3 30.0 ± 0.8 30.0 ± 0.8 24.5 ± 0.8 24.5 ± 0.8 22.2 ± 0.8
 Estradiol (pg/mL)3 10.0 ± 0.9 8.2 ± 1.0 6.7 ± 1.0 6.0 ± 0.9 5.5 ± 0.9
Age at blood draw (years) 55.1 ± 6.6 55.5 ± 6.8 56.1 ± 6.8 56.6 ± 6.8 58.1 ± 6.3
WCRF/AICR score components [mean ± SD]
 Body mass index (kg/m2) 31.1 ± 6.1 29.5 ± 6.0 26.3 ± 4.8 23.9 ± 3.1 22.6 ± 2.0
 Physical activity (MET-hrs/week) 2.9 ± 3.6 6.1 ± 10.4 16.8 ± 19.3 28.2 ± 23.2 35.6 ± 38.1
 Energy density (Kcal/100g/d) 788 ± 620 593 ± 361 520 ± 424 339 ± 301 153 ± 109
 Sugary drinks (g/d) 534 ± 1326 380 ± 1066 330 ± 1006 302 ± 936 232 ± 752
 Fruits and vegetables (g/d) 187 ± 749 244 ± 626 327 ± 702 489 ± 784 956 ± 847
 Dietary fiber (g/d) 13.3 ± 3.8 16.2 ± 4.2 17.8 ± 4.7 20.2 ± 5.5 25.0 ± 7.2
 Red meat (g/wk) 807 ± 1650 735 ± 1761 626 ± 1625 523 ± 1526 362 ± 1286
 Processed meat (g/d) 7.0 ± 20.9 4.3 ± 17.8 3.6 ± 22.5 2.4 ± 19.5 0.5 ± 2.2
 Alcohol (g/d) 21.8 ± 18.8 8.3 ± 13.6 5.6 ± 9.5 3.1 ± 5.0 1.9 ± 2.7
Smoking status (%)
 Never 29.9 39.5 42.5 47.5 49.5
 Former 37.9 42.2 42.7 41.7 43.3
 Current 32.2 18.3 14.8 10.9 7.2
Regular aspirin/NSAID user (%) 38.9 40.7 37.8 33.8 29.0
Chronic disease/conditions comorbidity score4
 no chronic disease/condition 38.9 35.9 41.1 43.3 42.3
 1 chronic disease/condition 28.9 29.8 31.0 33.0 32.4
 2 chronic diseases/conditions 19.4 21.1 17.9 16.6 18.1
 ≥3 chronic diseases/conditions 12.8 13.3 10.1 7.0 7.2
Postmenopausal women (%) 84.4 84.0 85.2 87.2 91.8
Postmenopausal hormone user (%) 41.7 46.8 52.4 56.9 64.7

Health Professionals Follow-up Study; 1994

0 to ≤2 (least adherent) (n1=235) >2 to ≤3 (n1=749) >3 to ≤4 (n1=2,296) >4 to ≤5 (n1=3,831) >5 to 6 (most adherent) (n1=1,025)

Plasma biomarkers [geometric mean ± CV]2
 C-reactive protein (mg/L) 1.3 ± 1.5 1.2 ± 1.3 1.1 ± 1.6 0.8 ± 1.4 0.7 ± 1.4
 Interleukin-6 (pg/mL) 2.0 ± 1.0 1.5 ± 1.1 1.5 ± 1.1 1.2 ± 1.4 1.2 ± 1.1
 tumor necrosis factor alpha receptor 2 (ng/ml) 2.7 ± 0.6 2.7 ± 0.6 2.7 ± 0.6 2.7 ± 0.6 2.7 ± 0.6
 Adiponectin (μg/mL) 5.5 ± 0.8 6.0 ± 0.8 6.0 ± 0.8 6.0 ± 0.8 6.7 ± 0.8
 C-peptide (ng/mL) 3.0 ± 0.9 2.7 ± 0.9 2.5 ± 0.9 2.2 ± 0.9 1.8 ± 0.9
 TG/HDL ratio 3.0 ± 1.1 3.0 ± 1.1 3.0 ± 1.1 2.7 ± 1.1 2.2 ± 1.0
Age at blood draw (years) 62.5 ± 9.1 61.8 ± 8.5 61.8 ± 8.5 62.1 ± 8.8 62.8 ± 8.9
WCRF/AICR score components [mean ± SD]
 Body mass index (kg/m2) 28.6 ± 5.5 28.0 ± 4.2 27.1 ± 3.6 25.4 ± 8.8 23.4 ± 1.7
 Physical activity (MET-hrs/week) 23.0 ± 38.7 23.6 ± 38.9 29.4 ± 35.1 43.0 ± 42.3 48.5 ± 38.4
 Energy density (Kcal/100g/d) 331 ± 185 330 ± 206 306 ± 182 276 ± 159 206 ± 107
 Sugary drinks (g/d) 441 ± 418 391 ± 374 313 ± 325 249 ± 257 192 ± 178
 Fruits and vegetables (g/d) 353 ± 219 357 ± 186 397 ±221 461 ± 261 605 ± 269
 Dietary fiber (g/d) 15.8 ± 4.7 18.8 ± 5.6 21.2 ± 6.5 23.8 ± 7.1 26.3 ± 8.0
 Red meat (g/wk) 671 ± 392 552 ± 449 491 ± 389 382 ± 324 275 ± 241
 Processed meat (g/d) 12.5 ± 14.6 10.0 ± 10.6 8.6 ± 10.8 6.7 ± 9.4 4.3 ± 6.2
 Alcohol (g/d) 25.4 ± 22.8 23.5 ± 22.6 16.2 ± 18.3 8.5 ± 10.4 6.0 ± 6.0
Smoking status (%)
 Never 33.2 37.0 39.5 49.3 54.9
 Former 54.9 52.7 53.4 46.1 41.5
 Current 11.9 10.3 7.2 4.6 3.6
Regular aspirin/NSAID user (%) 17.0 13.5 16.3 12.7 11.7
Chronic disease/conditions comorbidity score4
 no chronic disease/condition 34.9 37.3 38.5 42.4 45.9
 1 chronic disease/condition 30.6 30.7 34.3 31.5 30.8
 2 chronic diseases/conditions 20.4 20.2 16.5 17.4 14.7
 ≥3 chronic diseases/conditions 14.0 11.9 10.7 8.7 8.6
1

Biomarker sample sizes vary: in NHS, n=3,550 for all four inflammatory markers, n=5,834 for C-peptide, n=3,826 for TG/HDL ratio, n=1,217 for estrone, n=1,254 for estradiol; and in HPFS, n=5,157 for C-reactive protein, n=3,044 for interleukin-6, n=4,072 for tumor necrosis factor alpha receptor 2, n=4,348 for adiponectin, n=3,955 for C-peptide and n=3,575 for TG/HDL ratio in HPFS; TG=triglycerides, HDL=high density lipoprotein cholesterol. Sample size for all other characteristics is the total sample size;

2

Hormornes (estrone and estradiol) were examined only among postmenopausal women not using exogenous hormones

3

Geometric means (coefficient of variation, CV) are presented for biomarkers because all biomarkers were log transformed prior to analyses; The Quan-Zhang formula, CV=(eSD-1)1/2 was used to calculate CVs (ref #40);

4

Chronic diseases/conditions included in the score: hypercholesterolemia, cancer, diabetes, high blood pressure, heart disease, ulcerative colitis and rheumatoid/other arthritis.

TG=triglycerides, HDL=high density lipoprotein cholesterol.